Frequency of Th1, Th2 and Th17 producing T lymphocytes in bronchoalveolar lavage of patients with systemic sclerosis

Clinical and Experimental Rheumatology

Volumn 27, Issue 5, 2009, Pages 765-772

  Meloni, Federica ^a   Solari, Nadia ^a   Cavagna, Lorenzo ^b   Morosini, Monica ^a   Montecucco, Carlo Maurizio ^b   Fietta, Anna Maria ^a  

^a Section of Pneumology   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

BAL; ELISPOT; Sarcoidosis; SScFib+; SScFib ; Th1; Th2 and Th17 response; UIP

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12P40P70; INTERLEUKIN 17; INTERLEUKIN 5; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CAUSE OF DEATH; CONTROLLED STUDY; FEMALE; FIBROSING ALVEOLITIS; HUMAN; HUMAN CELL; INTERSTITIAL LUNG DISEASE; INTERSTITIAL PNEUMONIA; LUNG FIBROSIS; LUNG INJURY; LUNG LAVAGE; LUNG SARCOIDOSIS; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SYMPTOM; SYSTEMIC SCLEROSIS; TH1 CELL; TH17 CELL; TH2 CELL;

ADULT; AGED; BRONCHOALVEOLAR LAVAGE FLUID; CASE-CONTROL STUDIES; CELL COUNT; CROSS-SECTIONAL STUDIES; FEMALE; FIBROSIS; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-17; INTERLEUKIN-5; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; SARCOIDOSIS; SCLERODERMA, SYSTEMIC; T-LYMPHOCYTE SUBSETS; TH1 CELLS; TH2 CELLS; YOUNG ADULT;

EID: 72949097179     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. JIMENEZ SA, DERK CT: Following the molecular pathways toward an understanding of the pathogenesis of systemic sclerosis. Ann Intern Med 2004; 140: 37-50.
2. VARGA J, ABRAHAM D: Systemic sclerosis: a prototypic multisystem fibrotic disorder. J Clin Invest 2008; 117: 557-567
3. GU YS, KONG J, CHEEMA GS, KEEN CL, WICK G, GERSHWIN ME: The immunobiology of systemic sclerosis. Semin Arthritis Rheum 2008; 38: 132-160
4. VALENTINI G, MATUCCI CERINIC M: Disease-specific quality indicators, guidelines and outcome measures in sclerodermia. Clin Exp Rheumatol 2007; 25 (Suppl. 47): S159-62.
5. DU BOIS RM: Mechanisms of scleroderma-induced lung disease. Proc Am Thorac Soc 2007; 4: 434-438 (Pubitemid 47435367)
6. SAITO Y, TERADA M, TAKADA T et al.: Pulmonary involvement in mixed connective tissue disease: comparison with other collagen vascular diseases using high resolution CT. J Comput Assist Tomogr 2002; 26: 349-57.
7. WHITE B, MOORE WC, WIGLEY FM, XIAO HQ, WISE RA: Cyclophosphamide is associated with pulmunary function and survival benefit in patients with scleroderma and alveolitis. Ann Intern Med 2000; 132: 947-954
8. GOH NSL, DESAL SR, VEERARAGHAVAN S et al.: Interstitial lung disease in systemic sclerosis. Am J Respir Crit Care Med 2008; 177: 1248-1254 (Pubitemid 351860934)
9. CLEMENTS PJ, ROTH MD, ELASHOFF R et al.: Scleroderma lung study (SLS): differences in the presentation and course of patients with limited versus diffuse systemic sclerosis. Ann Rheum Dis 2007; 66: 1641-1647
10. GOH NSL, VEERARAGHAVAN S, DESAI SR et al.: Bronchoalveolar lavage cellular profiles in patients with systemic sclerosis-associated interstitial lung disease are not predictive of disease progression. Arthritis Rheum 2007; 56: 2005-2012
11. STRANGE C, BOLSTER MB, ROTH MD et al.: Bronchoalveolar lavage and response to cyclophosphamide in scleroderma interstitial lung disease. Am J Respir Crit Care Med 2008; 177: 91-98
12. TZELEPSIS GE, PLASTIRAS SC, KARADIMITRAKIS SP, VLACHOYIANNOPOULOS PG: Determinants of pulmonary function improvement in patients with scleroderma and interstitial lung disease. Clin Exp Rheumatol 2007; 25: 734-739 (Pubitemid 350284846)
13. KUMANOVICS G, MINIER T, RADICS J, PALINKAS L, BERKI T, CZIRJAK L: Comprehensive investigational of novel serum markers of pulmonary fibrosis associated with systemic sclerosis and dermato/polymyositis. Clin Exp Rheumatol 2008; 26: 414-420
14. SUZUKI N, OHTA K, HORIUCHi T et al.: T lymphocytes and silica-induced pulmonary inflammation and fibrosis in mice. Thorax 1996; 51: 1036-1042 (Pubitemid 26360181)
15. + T lymphocytes. J Leukoc Biol 1993; 54: 414-422
16. GOLDRING MB, SANDELL LJ, STEPHENSON ML: Immune interferon suppresses levels of procollagen mRNA and type II collagen synthesis in cultured human aricular and costal chondrocytes. J Immunol 1986; 261: 3049-56.
17. LUZINA IG, ATAMAS SP, WISE R, WIGLEY FM, XIAO HQ, WHITE B: Gene expression in bronchoalveolar lavage cells from scleroderma patients. Am J Respir Cell Mol Biol 2002; 26: 549-557 (Pubitemid 34315862)
18. LUKACS NW, HOGABOAM C, CHENSUE SW, BLEASE K, KUNKEL SL: Type 1/Type 2 cytokine paradigm and the progression of pulmonary fibrosis. Chest 2001; 120: 59-85.
19. AGOSTINI C, MENEGHIN A, SEMENZATO G: T-lymphocytes and cytokines in sarcoidosis. Curr Opin Pulm Med 2002; 8: 435-440
20. MELONI F, CAPORALI R, MARONE BIANCO A et al.: Cytokine profile of bronchoalveolar lavage in systemic sclerosis with interstitial lung disease: comparison with usual interstitial pneumonia. Ann Rheum Dis 2004; 63: 892-894
21. MELONI F, CAPORALI R, MARONE BIANCO A et al.: BAL cytokine profile in different interstitial lung disease: a focus on systemic sclerosis. Sarcoidosis Vasc Diffuse Lung Dis 2004; 21: 111-118
22. + lung cells is associated with greater decline in pulmonary function in patients with systemic sclerosis. Arthritis Rheum 1999; 42: 1168-1178
23. + T cells from scleroderma patients. Arthritis Rheum 2003; 48: 2262-2274
24. EDMÉ JL, TELLART AS, LAUNAY D et al.: Cytokine concentrations in exhaled breath condensates in systemic sclerosis. Inflamm Res 2008; 57: 151-156
25. BOIN F, DE FANIS U, BARTLETT SJ, WIGLEY FM, ROSEN A, CASOLARO V: T cell polarization identifies distinct clinical phenotypes in scleroderma lung disease. Arthritis Rheum 2008; 58: 1165-1174
26. ANTONELLI A, FERRI C, FALLAHI P et al.: CXCL10 (α) and CCL2 (β) chemokines in systemic sclerosis-a longitudinal study. Rheumatology 2008; 47: 45-49
27. ASARCH A, BARAK O, LOO DS, GOTTLIEB AB: Th17 cells: a new therapeutic target in inflammatory dermatoses. J Dermatol Treat 2008; 14: 1-9.
28. + T-cell subpopulation TH17 in the pathogenesis of systemic scleroderma. Nat Clin Pract Rheumatol 2007; 3: 682-683
29. KURASAWA K, HIROSE K, SANO H et al: Increased interleukin-17 production in patients with systemic sclerosis. Arthritis Rheum 2000; 43: 2455-2463 (Pubitemid 30829269)
30. MURATA M, FUJIMOTO M, MATSUSHITA T et al.: Clinical association of serum interleukin-17 levels in systemic sclerosis: is systemic sclerosis a Th17 disease? J Dermatol Sci 2008; 50: 240-242
31. BETTELLI E, KORN T, OUKKA M, KUCHROO VK: Induction and effector functions of Th17 cells. Nature 2008; 453: 1051-1057
32. MEDSGER TA JR, SILMAN AJ, STEEN VD et al.: A disease severity scale for systemic sclerosis: development and testing. J Rheumatol 1999; 26: 2159-2167 (Pubitemid 29487010)
33. STEEN V: Predictors of end stage lung disease in systemic sclerosis. Ann Rheum Dis 2003; 62: 97-99 (Pubitemid 36135382)
34. KAZEROONI EA, MARTINEZ FJ, FLINT A et al.: Thin-section CT obtained at 10-mm increments versus limited three-level thin-section CT for idiopathic pulmonary fibrosis: correlation with pathologic scoring. Am J Roentgenol 1997; 169: 977-983
35. AMERICAN THORAQC SOCIETY: Standardization of spirometry. 1994 update. Am J Respir CHt Care Med 1995; 152: 1107-1136
36. STATEMENT ON SARCOIDOSIS: Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG). Am J Respir Crit Care Med 1999; 160: 736-755
37. AMERICAN THORACIC SOCIETY/EUROPEAN RESPIRATORY SOCIETY INTERNATIONAL MULTIDISCIPLINARY CONSENSUS CLASSIFICATION OF THE IDIOPATHIC INTERSTITIAL PNEUMONIAS: This Joint Statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS Board of Directors, June 2001 and by The ERS Executive Committee, Am J Respir Crit Care Med 2001; 165: 277-304.
38. TECHNICAL RECOMMENDATIONS AND GUIDELINES FOR BRONCHOALVEOLAR LAVAGE (BAL): Report of the European Society of Pneumology Task Group. Eur Respir J 1989; 2: 561-585
39. MELONI F, PASCHETTO E, CASCINA A et al.: Evaluation with enzyme-linked immunosorbent assay spot detection of the frequency of interferon-gamma- producing T cells in bronchoalveolar lavage is useful in identifying lung transplant patients at higher risk of acute rejection. Transplant Proc 2001; 33: 3286-3288
40. SCHWANDER SK, TORRES M, CARRANZA CC et al.: Pulmonary mononuclear cell responses to antigens of mycobacterium tuberculosis in healthy household contacts of patients with active tuberculosis and healthy controls from the community. J Immunol 2000; 165: 1479-85.
41. MOROSINI M, MELONI F, UCCELLI M, MARONE BIANCO A, SOLARI N, FIETTA AM: Ex vivo evaluation of purified protein derivative-specific IFN-γ or IL-5 secreting cells in the peripheral blood and lungs of patients with tubercolosis. Int J Tuberc Lung Dis 2005; 9: 753-759
42. WANGOO A, SPARER T, BROWN IN et al.: Contribution of Th1 and Th2 cells to protection and pathology in experimental models of granulomatous lung disease. J Immunol 2001; 166: 3432-3439
43. WALLACE WA, HOWIE SE: Immunoreactive Interleukin-4 and Interferon-gamma expression by type II alveolar epithelial cells in interstitial lung disease. J Pathol 1999; 187: 475-480
44. CHIZZOLINI C: T cells, B cells, and polarized immune response in the pathogenesis of fibrosis and systemic sclerosis. Curr Opin Rheumatol 2008; 20: 707-712
45. BOIN F, DE FANIS U, BARTLETT SJ, WlGLEY FM, ROSEN A, CASOLARO V: T cell polarization identifies distinct clinical phenotypes in scleroderma lung disease. Arthritis Rheum 2008; 58: 1165-1174
46. BOUROS D, WELLS AU, NICHOLSON AG et al.: Histopathologic subsets of fibrosis alveolitis in patients with systemic sclerosis and their relationship to outcome. Am J Respir Crit Care Med 2002; 165: 1581-1586
47. JAKUBZICK C, CHOI ES, KUNKEL SL et al.: Augmented pulmonary IL-4 and IL-13 recepter subunit expression in idiopathic interstizial pneumonia. J Clin Pathol 2004; 57: 477-486
48. CHOI ES, JAKUBZICK C, CARPENTER KJ et al.: Enhanced monocyte chemoattractant protein-3/CC chemokine ligand-7 in usual interstitial pneumonia. Am J Respir Crit Care Med 2004; 170: 508-515
49. YOSHIOKA S, MUKAE H, SUGIYAMA K et al.: High-BAL fluid concentrations of RANTES in non specific interstitial pneumonia compared with usual interstitial pneumonia. Respir Med 2004; 98: 945-951
50. TESMER LA, LUNDY SK, SARKAR S, FOX DA: Th17 cells in human diseases. Immunol Rev 2008; 223: 87-113.